GL173-RFA-lumbar-sacral-64635-64636 - Oregon



In January 2018, these codes were moved to Guideline Note 173.64635-64636 Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacralLast reviewed by HERC 11/13/2014 as a part of the coverage guidance rescan process for the coverage guidance on Percutaneous Interventions for Low Back Pain. The recommendation against coverage was maintained, and coverage was not added to the Prioritized List. Minutes indicate the HERC requested an update of this coverage guidance once an updated report is available. As of July, 2017, this new report (Low Back Pain: Minimally Invasive and Non-Corticosteroid Percutaneous Interventions) is currently under development. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download